UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of baseline insomnia in moderating the hypnotic properties of quetiapine

Addictive behaviors, 2023-05, Vol.140, p.107622-107622, Article 107622

2023

Volltextzugriff (PDF)

Case–control association analysis of polymorphisms in the delta-opioid receptor, OPRD1 , with cocaine and opioid addicted populations

Drug and alcohol dependence, 2013-01, Vol.127 (1), p.122-128

2013

Volltextzugriff (PDF)

A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment

Drug and alcohol dependence, 2016-09, Vol.166, p.268-271

2016

Volltextzugriff (PDF)

American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use

Journal of addiction medicine, 2015-09, Vol.9 (5), p.358-367

2015

Volltextzugriff (PDF)

Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction

Genes, brain and behavior, 2012-06, Vol.11 (4), p.415-423

2012

Volltextzugriff (PDF)

Reliability and validity of the cocaine selective severity assessment

Addictive behaviors, 1998-07, Vol.23 (4), p.449-461

1998

Volltextzugriff (PDF)

Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study

Drug and alcohol dependence, 2003-05, Vol.70 (1), p.29-37

2003

Volltextzugriff (PDF)

Cocaine Withdrawal Symptoms and Initial Urine Toxicology Results Predict Treatment Attrition in Outpatient Cocaine Dependence Treatment

Psychology of addictive behaviors, 2001-03, Vol.15 (1), p.52-59

2001

Volltextzugriff (PDF)

Amantadine in the Treatment of Cocaine-Dependent Patients With Severe Withdrawal Symptoms

The American journal of psychiatry, 2000-12, Vol.157 (12), p.2052-2054

2000

Volltextzugriff (PDF)

Oscillatory activity and cortical coherence of the nucleus basalis of Meynert in Parkinson's disease dementia

Parkinsonism & related disorders, 2018-07, Vol.52, p.102-106

2018

Volltextzugriff (PDF)

0977 The Association Between Alcohol Craving And Insomnia Symptoms In Alcohol Dependent Individuals

Sleep (New York, N.Y.), 2018-04, Vol.41 (suppl_1), p.A362-A363

2018

Volltextzugriff (PDF)

Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity

Drug and alcohol dependence, 2001-06, Vol.63 (1), p.69-78

2001

Volltextzugriff (PDF)

Tolerance and Sensitization to the Effects of Cocaine Use in Humans: A Retrospective Study of Long-Term Cocaine Users in Philadelphia

Substance use & misuse, 2009-12, Vol.44 (13), p.1888-1898

2009

Volltextzugriff (PDF)

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial

JAMA internal medicine, 2018-06, Vol.178 (6), p.764

2018

Volltextzugriff (PDF)

The Effects of Naltrexone on Alcohol and Cocaine Use in Dually Addicted Patients

Journal of substance abuse treatment, 1999-03, Vol.16 (2), p.163-167

1999

Volltextzugriff (PDF)

AN OPRD1 VARIANT PREDICTS CONTINUED OPIOID USE IN AFRICAN-AMERICANS UNDERGOING BUPRENORPHINE TREATMENT

European neuropsychopharmacology, 2019, Vol.29, p.S936

2019

Volltextzugriff (PDF)

Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2010-10, Vol.304 (14), p.1576

2010

Volltextzugriff (PDF)

Sustained brain response to repeated drug cues is associated with poor drug‐use outcomes

Addiction biology, 2021-09, Vol.26 (5), p.e13028-n/a

2021

Volltextzugriff (PDF)

A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Neuropsychopharmacology (New York, N.Y.), 2005-01, Vol.30 (1), p.205-211

2005

Volltextzugriff (PDF)

What’s New in the Treatment of Cocaine Addiction?

Current psychiatry reports, 2010-10, Vol.12 (5), p.441-447

Kampman, Kyle M.

2010

Volltextzugriff (PDF)

A pilot trial of topiramate for the treatment of cocaine dependence

Drug and alcohol dependence, 2004-09, Vol.75 (3), p.233-240

2004

Volltextzugriff (PDF)

Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence

Addictive behaviors, 1999-03, Vol.24 (2), p.287-291

1999

Volltextzugriff (PDF)

Biomarkers for the Development of New Medications for Cocaine Dependence

Neuropsychopharmacology (New York, N.Y.), 2014-01, Vol.39 (1), p.202-219

2014

Volltextzugriff (PDF)

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking

Journal of clinical psychopharmacology, 2006-12, Vol.26 (6), p.610-625

2006

Volltextzugriff (PDF)

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism

Journal of clinical psychopharmacology, 2007-08, Vol.27 (4), p.344-351

2007

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(189)

Publikationsform

Erscheinungsjahr

n.n

Thema

Science & Technology
(180)
Life Sciences & Biomedicine
(176)
Humans
(140)
Female
(100)
Male
(97)
Middle Aged
(76)
Adult
(73)
Biological And Medical Sciences
(60)
Medical Sciences
(54)
Psychiatry
(48)
Risk Factors
(37)
Aged
(34)
Oncology
(34)
Substance Abuse
(34)
Medicin Och Hälsovetenskap
(32)
Cancer
(30)
Cocaine
(28)
Psychology. Psychoanalysis. Psychiatry
(28)
Colorectal Cancer
(26)
Neurosciences & Neurology
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The role of baseline insomnia in moderating the hypnotic properties of quetiapine

Case–control association analysis of polymorphisms in the delta-opioid receptor, OPRD1 , with cocaine and opioid addicted populations

A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment

American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use

Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction

Reliability and validity of the cocaine selective severity assessment

Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study

Cocaine Withdrawal Symptoms and Initial Urine Toxicology Results Predict Treatment Attrition in Outpatient Cocaine Dependence Treatment

Amantadine in the Treatment of Cocaine-Dependent Patients With Severe Withdrawal Symptoms

Oscillatory activity and cortical coherence of the nucleus basalis of Meynert in Parkinson's disease dementia

0977 The Association Between Alcohol Craving And Insomnia Symptoms In Alcohol Dependent Individuals

Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity

Tolerance and Sensitization to the Effects of Cocaine Use in Humans: A Retrospective Study of Long-Term Cocaine Users in Philadelphia

Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial

The Effects of Naltrexone on Alcohol and Cocaine Use in Dually Addicted Patients

AN OPRD1 VARIANT PREDICTS CONTINUED OPIOID USE IN AFRICAN-AMERICANS UNDERGOING BUPRENORPHINE TREATMENT

Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial

Sustained brain response to repeated drug cues is associated with poor drug‐use outcomes

A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence

What’s New in the Treatment of Cocaine Addiction?

A pilot trial of topiramate for the treatment of cocaine dependence

Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence

Biomarkers for the Development of New Medications for Cocaine Dependence

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism

Aktive Filter

Suchergebnisse filtern